Related Experiment Video

Updated: Aug 30, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Metastatic breast cancer: overview of treatment

S M Ali1, H A Harvey, Allan Lipton

  • 1M S Hershey Medical Center, Hershey, PA, USA. Suhail.Ali@med.va.gov

Clinical Orthopaedics and Related Research
|November 6, 2003
PubMed

Insights

Metastatic breast cancer patients face a grim prognosis, with survival typically 2-3 years. Advances in endocrine and chemotherapy offer new hope for improving quality of life and prolonging survival for these patients.

Area of Science:

  • Oncology
  • Medical Therapeutics

Background:

  • Metastatic breast cancer (MBC) presents a significant survival challenge, with a median survival of 2-3 years.
  • A subset of patients with bone-only metastasis shows a 5-year survival rate of 20%.

Purpose of the Study:

  • To review recent advancements in the treatment of metastatic breast cancer.
  • To highlight new therapeutic options for oncologists managing MBC.

Main Methods:

  • Literature review of current and emerging treatments for metastatic breast cancer.
  • Analysis of the impact of new endocrine and chemotherapeutic agents.

Main Results:

  • New endocrine and chemotherapeutic drugs are expanding treatment options for MBC.
  • These newer agents aim to improve patient quality of life and survival outcomes.

Conclusions:

  • Ongoing research and development are crucial for improving MBC patient outcomes.
  • The integration of novel therapies holds promise for better disease management.

More Related Videos

Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy05:05

Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy

Published on: November 29, 2018

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...